Inogen Inc Cash Flow Conversion Efficiency
Inogen Inc cash flow conversion efficiency. Based on the latest financial reports, Inogen Inc (INGN) has a cash flow conversion efficiency ratio of -0.037x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-6.68 Million) by net assets ($182.91 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Inogen Inc (2011–2025)
Cash flow conversion efficiency of Inogen Inc from 2011 to 2025. This chart illustrates how Inogen Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Inogen Inc share price for real-time trading data and today's change.
Inogen Inc Cash Flow Conversion Ratio Explained
Inogen Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Inogen Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Inogen Inc ranked by their cash flow conversion efficiency. Also see INGN market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Multi Spunindo Jaya Tbk.
JK:MSJA
|
0.042x |
|
JF Technology BHD
KLSE:0146
|
-0.007x |
|
United Paper Public Company Limited
BK:UTP
|
0.036x |
|
Export Inv
TA:EXPO
|
0.037x |
|
Stereotaxis Inc
NYSE MKT:STXS
|
-0.364x |
|
Petronor E&P Ltd
OL:PNOR
|
-0.047x |
|
Dynamix Corporation
NASDAQ:ETHM
|
0.214x |
|
Marblegate Acquisition Corp
NASDAQ:GATE
|
0.017x |
Annual Cash Flow Conversion Efficiency for Inogen Inc (2011–2025)
The table below shows the annual cash flow conversion efficiency of Inogen Inc from 2011 to 2025. Review INGN free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $192.23 Million | $-11.22 Million | -0.058x | -271.53% |
| 2024-12-31 | $173.86 Million | $5.91 Million | 0.034x | +315.43% |
| 2023-12-31 | $204.81 Million | $-3.23 Million | -0.016x | +87.49% |
| 2022-12-31 | $297.41 Million | $-37.53 Million | -0.126x | -297.70% |
| 2021-12-31 | $370.23 Million | $23.63 Million | 0.064x | -39.70% |
| 2020-12-31 | $349.62 Million | $37.01 Million | 0.106x | -10.12% |
| 2019-12-31 | $344.62 Million | $40.59 Million | 0.118x | -39.04% |
| 2018-12-31 | $310.42 Million | $59.98 Million | 0.193x | -27.49% |
| 2017-12-31 | $227.04 Million | $60.49 Million | 0.266x | +56.33% |
| 2016-12-31 | $182.09 Million | $31.03 Million | 0.170x | -40.15% |
| 2015-12-31 | $134.02 Million | $38.16 Million | 0.285x | +114.33% |
| 2014-12-31 | $118.15 Million | $15.70 Million | 0.133x | -44.46% |
| 2013-12-31 | $56.30 Million | $13.47 Million | 0.239x | +70.71% |
| 2012-12-31 | $28.57 Million | $4.00 Million | 0.140x | -43.05% |
| 2011-12-31 | $7.56 Million | $1.86 Million | 0.246x | -- |
About Inogen Inc
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen the… Read more